GERON CORPORATION INVESTOR ALERT: Girard Gibbs Investigates Potential Securities Law Violations

GERON CORPORATION INVESTOR ALERT: Girard Gibbs Investigates Potential Securities Law Violations

Girard Gibbs LLP is investigating claims on behalf of investors of Geron
Corporation (NASDAQ:GERN) involving possible securities law violations.
Specifically, our investigation focuses on allegations that Geron may
have issued materially misleading business information to the investing

To speak privately with an attorney regarding this class action
lawsuit investigation, click

On March 27, 2018, STAT, a news organization focused on medical industry
reporting, published an article alleging that Geron’s recent stock gains
were due to “flimsy” claims regarding the efficacy of Imetelstat,
Geron’s experimental treatment for myelofibrosis. The report further
states that available data for Imetelstat does not support Geron’s
representations about the drug’s efficacy.

Following the publication of the STAT article on March 27, 2018, shares
of Geron dropped by more than 13% to close at $5.15 per share. The stock
continued to plummet into the next day of trading, closing down 17.86%
on March 28, 2018, and causing significant harm to investors.

If you purchased or acquired shares of Geron Corporation and would like
to speak privately with a securities attorney to learn more about the
investigation and your legal rights, visit our website
or contact the securities team directly at (800) 254-9493.

Girard Gibbs LLP is one of the nation’s leading firms representing
individual and institutional investors in securities
litigation to correct abusive corporate governance practices,
breaches of fiduciary duty, and proxy violations. The firm has recovered
over a billion dollars for its clients against some of the world’s
largest corporations, and has earned Tier-1 rankings and been named in
the U.S.
Lawyers – Best Law Firms list for five consecutive years.

This press release may constitute Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

View source version on

SOURCE: Girard Gibbs LLP

Girard Gibbs LLP 
Eileen Epstein, 510-350-9728

Copyright Business Wire 2018


As of Saturday, 03-24-2018 23:59, the latest Comtex SmarTrend® Alert,
an automated pattern recognition system, indicated a DOWNTREND on
03-15-2012 for

Go to Source